Hogy Medical Co.,Ltd. (TYO:3593)
Japan · Delayed Price · Currency is JPY 6,660.00
0.00 (0.00%)
Inactive · Last trade price on May 14, 2026
Hogy Medical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 143,583 | 103,488 | 91,028 | 77,016 | 93,319 | 102,087 | |
Market Cap Growth | 63.83% | 13.69% | 18.19% | -17.47% | -8.59% | 0.40% |
Enterprise Value | 137,476 | 96,435 | 79,042 | 69,063 | 76,098 | 81,454 |
Last Close Price | 6660.00 | 4750.90 | 3646.54 | 3016.53 | 3011.52 | 3073.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | 646.77 | 68.08 | 32.46 | 17.84 | 21.35 | 20.59 |
Forward PE | - | 31.13 | 24.57 | 17.42 | 19.46 | 20.36 |
PS Ratio | 3.79 | 2.64 | 2.33 | 1.98 | 2.54 | 2.80 |
PB Ratio | 1.93 | 1.39 | 1.06 | 0.92 | 1.17 | 1.06 |
P/TBV Ratio | 1.94 | 1.40 | 1.06 | 0.93 | 1.19 | 1.09 |
P/FCF Ratio | 740.12 | 16.36 | 20.54 | 9.80 | 17.11 | - |
P/OCF Ratio | 25.40 | 8.96 | 12.79 | 8.39 | 10.98 | 14.89 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
EV/Sales Ratio | 3.63 | 2.46 | 2.02 | 1.77 | 2.07 | 2.23 |
EV/EBITDA Ratio | 17.37 | 10.29 | 7.34 | 6.74 | 7.42 | 8.00 |
EV/EBIT Ratio | 55.61 | 26.58 | 18.96 | 10.41 | 12.40 | 14.46 |
EV/FCF Ratio | 708.64 | 15.25 | 17.84 | 8.79 | 13.96 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Debt / Equity Ratio | 0.16 | 0.19 | 0.07 | 0.11 | 0.13 | 0.00 |
Debt / EBITDA Ratio | 1.54 | 1.47 | 0.54 | 0.87 | 0.98 | 0.03 |
Debt / FCF Ratio | 62.73 | 2.18 | 1.31 | 1.13 | 1.83 | - |
Net Debt / Equity Ratio | -0.08 | -0.11 | -0.16 | -0.12 | -0.05 | -0.21 |
Net Debt / EBITDA Ratio | -0.77 | -0.88 | -1.26 | -0.97 | -0.42 | -1.99 |
Net Debt / FCF Ratio | -31.52 | -1.30 | -3.07 | -1.27 | -0.80 | 40.76 |
Asset Turnover | 0.39 | 0.40 | 0.39 | 0.39 | 0.36 | 0.34 |
Inventory Turnover | 2.75 | 2.73 | 2.84 | 2.63 | 2.42 | 2.54 |
Quick Ratio | 3.98 | 3.22 | 3.91 | 2.77 | 2.75 | 4.21 |
Current Ratio | 5.34 | 4.26 | 5.22 | 3.62 | 3.78 | 5.44 |
Return on Equity (ROE) | 0.30% | 1.90% | 3.29% | 5.24% | 4.93% | 5.19% |
Return on Assets (ROA) | 1.60% | 2.29% | 2.58% | 4.12% | 3.75% | 3.32% |
Return on Invested Capital (ROIC) | 0.76% | 2.71% | 3.91% | 6.15% | 5.59% | 5.40% |
Return on Capital Employed (ROCE) | 2.90% | 4.10% | 4.50% | 7.30% | 6.80% | 5.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 13, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Earnings Yield | 0.15% | 1.47% | 3.08% | 5.60% | 4.68% | 4.86% |
FCF Yield | 0.14% | 6.11% | 4.87% | 10.20% | 5.84% | -0.49% |
Dividend Yield | 0.71% | 1.68% | 2.19% | 2.35% | 2.26% | 2.21% |
Payout Ratio | 849.10% | 120.59% | 67.47% | 39.32% | 45.65% | 41.22% |
Buyback Yield / Dilution | 6.43% | 7.82% | -0.04% | 15.08% | 5.52% | -0.09% |
Total Shareholder Return | 7.14% | 9.50% | 2.15% | 17.43% | 7.78% | 2.12% |